Eversept Partners’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Eversept Partners's DNA Position: Q3 2026 in Review
Eversept Partners opened a new position in Ginkgo Bioworks (DNA) in Q3 2026: 37,227 shares worth $478K. The stake represents 0.03% of the portfolio and ranks #103 among its holdings.
183 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Eversept Partners held 37,227 shares of Ginkgo Bioworks worth $478K as of Q3 2026.
- Ginkgo Bioworks was a new Eversept Partners position in Q3 2026.
- Ginkgo Bioworks made up 0.03% of Eversept Partners's portfolio in Q3 2026, its #103 holding.
- 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.